[Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation]

Gastroenterol Hepatol. 2004 Feb:27 Suppl 1:52-6.

[Article in Spanish]

Authors

M de la Mata¹, P Barrera, J L Montero, E Fraga, J Briceño, J C Pozo, G Solórzano

Affiliation

¹ Unidad de Trasplante Hepático, Hospital Universitario Reina Sofía, Avda. Menéndez Pidal, s/n, 14004 Córdoba, España.

PMID: 15195535

No abstract available

Publication types

Review

MeSH terms

Antilymphocyte Serum / therapeutic use
Carcinoma, Hepatocellular / surgery
Cardiovascular Diseases / epidemiology
Cardiovascular Diseases / etiology
Case Management
Graft Rejection / immunology*
Graft Rejection / prevention & control
HIV Infections / complications
Hepatitis C / complications
Humans
Immunosuppression Therapy / methods*
Immunosuppressive Agents / classification
Immunosuppressive Agents / pharmacology
Immunosuppressive Agents / therapeutic use
Kidney Failure, Chronic / complications
Liver Neoplasms / surgery
Liver Transplantation*
Risk
T-Lymphocytes

Substances

Antilymphocyte Serum
Immunosuppressive Agents